Ignite Creation Date:
2025-12-25 @ 12:29 AM
Ignite Modification Date:
2025-12-25 @ 10:35 PM
Study NCT ID:
NCT00395967
Status:
TERMINATED
Last Update Posted:
2015-05-01
First Post:
2006-11-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone
Sponsor:
Genzyme, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04
Start Date Type:
None
Primary Completion Date:
2005-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-08
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-02
First Submit QC Date:
None
Study First Post Date:
2006-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-01-27
Results First Submit QC Date:
None
Results First Post Date:
2010-08-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-04-10
Last Update Post Date:
2015-05-01
Last Update Post Date Type:
ESTIMATED